| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Barrow Robert is a Chief Executive Officer at MNMD with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $26.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | DFTX Definium Therapeutics, Inc. | Chief Executive Officer | Sell | 24,431 | $18.47 | $451,240.57 | -3.1% | - | - | |
| Dec 26, 2025 | Chief Executive Officer | Sell | 25,791 | $13.15 | $339,071.70 | -3.2% | - | - | ||
| Sep 25, 2025 | Chief Executive Officer | Sell | 25,797 | $9.77 | $252,036.69 | -3.1% | - | - | ||
| Jun 25, 2025 | Chief Executive Officer | Sell | 26,491 | $6.80 | $180,138.80 | -3.1% | - | - | ||
| Mar 25, 2025 | Chief Executive Officer | Sell | 21,208 | $6.74 | $142,941.92 | -2.4% | - | - | ||
| Dec 26, 2024 | Chief Executive Officer | Sell | 19,106 | $7.43 | $141,957.58 | -3.5% | - | - | ||
| Sep 25, 2024 | Chief Executive Officer | Sell | 19,771 | $5.98 | $118,230.58 | -3.5% | - | - | ||
| Aug 20, 2024 | Chief Executive Officer | Buy | 1,000 | $6.22 | $6,215.00 | - | - | - | ||
| Jun 25, 2024 | Chief Executive Officer | Sell | 15,659 | $7.22 | $113,057.98 | -2.7% | - | - | ||
| Mar 25, 2024 | Chief Executive Officer | Sell | 16,519 | $9.50 | $156,930.50 | -2.8% | - | - |